Want to see JP:7780 full AI Analyst Report?
7780 Stock Chart & Stats
¥1597.00
-¥6.00(-0.44%)
At close: 4:00 PM EST
¥1597.00
-¥6.00(-0.44%)
Day’s Range― - ―
52-Week Range¥1,090.00 - ¥2,086.00
Previous CloseN/A
Volume259.20K
Average Volume (3M)317.29K
Market Cap
¥132.02B
Enterprise Value¥167.99K
Total Cash (Recent Filing)¥32.61B
Total Debt (Recent Filing)¥74.18B
Price to Earnings (P/E)21.9
Beta0.64
Next Earnings
Nov 16, 2026Next Dividend Ex-DateN/A
Dividend Yield1.61%
Share Statistics
EPS (TTM)79.34
Shares Outstanding76,771,484
10 Day Avg. Volume331,470
30 Day Avg. Volume317,293
Financial Highlights & Ratios
PEG Ratio3.13
Price to Book (P/B)1.34
Price to Sales (P/S)1.01
P/FCF Ratio-37.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥2,100.00Price Target Upside31.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)89.79
Revenue Forecast (FY)¥132.29B
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthMulti-year top-line expansion demonstrates durable demand for Menicon's contact lenses and care products and supports scale advantages. Consistent revenue growth provides a foundation for reinvestment, distribution network strength, and longer-term product development funding.
Strong Gross MarginsSustained 52–54% gross margins indicate structurally favorable product economics and pricing/production advantages in core lens and care businesses. This margin resilience helps absorb SG&A and R&D while supporting long-term operating profitability if top-line momentum continues.
Growing Equity BaseA materially larger equity base strengthens capital buffers and solvency, enabling strategic investments and cushioning against cyclical shocks. Higher equity supports credit capacity and long-term financing options for product development and international expansion initiatives.
Bears Say
Persistent Negative Free Cash FlowRecurring negative free cash flow signals that investments or working-capital drains exceed operating cash generation. Over time this can constrain discretionary spending, dividend sustainability, debt repayment capacity and may force external financing or slower organic growth.
Weak Cash ConversionLow conversion of accounting profits into cash raises concerns about earnings quality and liquidity under stress. Persistent divergence limits flexibility to fund capex or repay debt from operations and heightens reliance on external financing or equity issuance over the medium term.
Rising Leverage And Moderating ROEIncreasing leverage combined with falling ROE suggests less efficient capital deployment and higher financial risk. Over months this reduces strategic optionality, raises interest burden sensitivity, and can pressure margins or investment plans if earnings recovery lags.
Menicon Co News
7780 FAQ
What was Menicon Co Ltd’s price range in the past 12 months?
Menicon Co Ltd lowest stock price was ¥1090.00 and its highest was ¥2086.00 in the past 12 months.
What is Menicon Co Ltd’s market cap?
Menicon Co Ltd’s market cap is ¥132.02B.
When is Menicon Co Ltd’s upcoming earnings report date?
Menicon Co Ltd’s upcoming earnings report date is Nov 16, 2026 which is in 98 days.
How were Menicon Co Ltd’s earnings last quarter?
Menicon Co Ltd released its earnings results on Aug 07, 2026. The company reported ¥30.05 earnings per share for the quarter, beating the consensus estimate of ¥16 by ¥14.05.
Is Menicon Co Ltd overvalued?
According to Wall Street analysts Menicon Co Ltd’s price is currently Undervalued.
Does Menicon Co Ltd pay dividends?
Menicon Co Ltd pays a Annually dividend of ¥28 which represents an annual dividend yield of 1.61%. See more information on Menicon Co Ltd dividends here
What is Menicon Co Ltd’s EPS estimate?
Menicon Co Ltd’s EPS estimate is 24.
How many shares outstanding does Menicon Co Ltd have?
Menicon Co Ltd has 76,771,484 shares outstanding.
What happened to Menicon Co Ltd’s price movement after its last earnings report?
Menicon Co Ltd reported an EPS of ¥30.05 in its last earnings report, beating expectations of ¥16. Following the earnings report the stock price went up 14.931%.
Which hedge fund is a major shareholder of Menicon Co Ltd?
Currently, no hedge funds are holding shares in JP:7780
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Menicon Co Ltd
Menicon Co., Ltd. (7780) is a Japan-based medical device company focused on vision care. It develops, manufactures, and sells contact lenses and related eye-care products, and is also involved in ophthalmic solutions and associated services supporting contact lens use.
7780 Stock 12 Month Forecast
Average Price Target
¥2,100.00
▲(31.50% Upside)
Technical Analysis
HOYA
―
JINS HOLDINGS
―
Japan Eyewear Holdings Co.,Ltd.
―
Mani, Inc.
―
Seed Co., Ltd.
―









